Rodríguez I, Fluiters E, Pérez-Méndez L F, Luna R, Páramo C, García-Mayor R V
Endocrine Department, University Hospital of Vigo, Vigo, Spain.
J Endocrinol. 2004 Feb;180(2):347-50. doi: 10.1677/joe.0.1800347.
This study was carried out to investigate the clinical and biochemical factors which might be of importance in predicting the outcome of patients with myxoedema coma. Eleven patients (ten female) aged 68.1+/-19.5 years attended our institution over a period of 18 years. Glasgow and APACHE II scores and serum free thyroxine and TSH were measured in all the patients on entry. Patients were selected at random to be treated with two different regimens of l-thyroxine. Four patients died with the mortality rate being 36.4%. The patients in coma at entry had significantly higher mortality rates than those with minor degrees of consciousness (75% vs 14.3% respectively, P=0.04). The surviving patients had significantly higher Glasgow scores than those who died (11.85+/-2.3 vs 5.25+/-2.2 respectively, P<0.001). Comparison of the mean values of APACHE II scores between the surviving group and those who died was significantly different (18.0+/-2.08 vs 31.5+/-2.08 respectively, P<0.0001). The degree of consciousness, the Glasgow score and the severity of the illness measured by APACHE II score on entry were the main factors that determined the post-treatment outcome of patients with myxoedema coma.
本研究旨在调查可能对预测黏液性水肿昏迷患者预后具有重要意义的临床和生化因素。在18年的时间里,11名患者(10名女性)年龄为68.1±19.5岁,到我们机构就诊。所有患者入院时均测量了格拉斯哥评分和急性生理与慢性健康状况评分系统(APACHE II)评分以及血清游离甲状腺素和促甲状腺激素。患者被随机选择接受两种不同方案的左甲状腺素治疗。4名患者死亡,死亡率为36.4%。入院时处于昏迷状态的患者死亡率显著高于意识障碍较轻的患者(分别为75%和14.3%,P = 0.04)。存活患者的格拉斯哥评分显著高于死亡患者(分别为11.85±2.3和5.25±2.2,P<0.001)。存活组和死亡组之间APACHE II评分的平均值比较有显著差异(分别为18.0±2.08和31.5±2.08,P<0.0001)。入院时的意识程度、格拉斯哥评分以及用APACHE II评分衡量的疾病严重程度是决定黏液性水肿昏迷患者治疗后预后的主要因素。